Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 224

    1.

    Correlation between erythrocyte aldose reductase level and human diabetic retinopathy.

    Oishi N, Kubo E, Takamura Y, Maekawa K, Tanimoto T, Akagi Y.

    Br J Ophthalmol. 2002 Dec;86(12):1363-6.PMID: 12446366 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    High levels of erythrocyte aldose reductase and diabetic retinopathy in NIDDM patients.

    Nishimura C, Saito T, Ito T, Omori Y, Tanimoto T.

    Diabetologia. 1994 Mar;37(3):328-30.PMID: 8174849 [PubMed - indexed for MEDLINE]Related articles

    3.

    The level of erythrocyte aldose reductase is associated with the severity of diabetic retinopathy.

    Nishimura C, Hotta Y, Gui T, Seko A, Fujimaki T, Ishikawa T, Hayakawa M, Kanai A, Saito T.

    Diabetes Res Clin Pract. 1997 Sep;37(3):173-7.PMID: 9306038 [PubMed - indexed for MEDLINE]Related articles

    4.

    The level of erythrocyte aldose reductase: a risk factor for diabetic neuropathy?

    Ito T, Nishimura C, Takahashi Y, Saito T, Omori Y.

    Diabetes Res Clin Pract. 1997 Jun;36(3):161-7.PMID: 9237782 [PubMed - indexed for MEDLINE]Related articles

    5.

    Increased levels of aldose reductase in peripheral mononuclear cells from type 2 diabetic patients with microangiopathy.

    Hasegawa G, Obayashi H, Kitamura A, Hashimoto M, Shigeta H, Nakamura N, Kondo M, Nishimura CY.

    Diabetes Res Clin Pract. 1999 Aug;45(1):9-14.PMID: 10499880 [PubMed - indexed for MEDLINE]Related articles

    6.

    Association of erythrocyte aldose reductase activity with diabetic complications in type 1 diabetes mellitus.

    Hamada Y, Kitoh R, Raskin P.

    Diabet Med. 1993 Jan-Feb;10(1):33-8. Erratum in: Diabet Med 1993 Apr;10(3):197. PMID: 8435985 [PubMed - indexed for MEDLINE]Related articles

    7.

    Relations between diabetic retinopathy and cardiovascular neuropathy--a cross-sectional study in IDDM and NIDDM patients.

    Zander E, Heinke P, Herfurth S, Reindel J, Ostermann FE, Kerner W.

    Exp Clin Endocrinol Diabetes. 1997;105(6):319-26.PMID: 9439926 [PubMed - indexed for MEDLINE]Related articles

    8.

    Correlation between adult diabetic cataracts and red blood cell aldose reductase levels.

    Oishi N, Morikubo S, Takamura Y, Kubo E, Tsuzuki S, Tanimoto T, Akagi Y.

    Invest Ophthalmol Vis Sci. 2006 May;47(5):2061-4.PMID: 16639016 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Epalrestat, an aldose reductase ihibitor, reduces the levels of Nepsilon-(carboxymethyl)lysine protein adducts and their precursors in erythrocytes from diabetic patients.

    Hamada Y, Nakamura J, Naruse K, Komori T, Kato K, Kasuya Y, Nagai R, Horiuchi S, Hotta N.

    Diabetes Care. 2000 Oct;23(10):1539-44.PMID: 11023149 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Erythrocyte aldose reductase activity and sorbitol levels in diabetic retinopathy.

    Reddy GB, Satyanarayana A, Balakrishna N, Ayyagari R, Padma M, Viswanath K, Petrash JM.

    Mol Vis. 2008 Mar 24;14:593-601.PMID: 18385795 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Increased plasma urotensin-II levels are associated with diabetic retinopathy and carotid atherosclerosis in Type 2 diabetes.

    Suguro T, Watanabe T, Kodate S, Xu G, Hirano T, Adachi M, Miyazaki A.

    Clin Sci (Lond). 2008 Dec;115(11):327-34.PMID: 18338983 [PubMed - indexed for MEDLINE]Related articles

    12.

    No correlation between glycemic control and an increase in erythrocyte aldose reductase activity in type I and type II diabetic patients.

    Hamada Y, Hammon K, Raskin P.

    J Diabetes Complications. 1992 Apr-Jun;6(2):111-5.PMID: 1611134 [PubMed - indexed for MEDLINE]Related articles

    13.

    Erythrocyte aldose reductase protein: a clue to elucidate risk factors for diabetic neuropathies independent of glycemic control.

    Takahashi Y, Tachikawa T, Ito T, Takayama S, Omori Y, Iwamoto Y.

    Diabetes Res Clin Pract. 1998 Nov;42(2):101-7.PMID: 9886746 [PubMed - indexed for MEDLINE]Related articles

    14.

    Epithelial cell density in cataractous lenses of patients with diabetes: association with erythrocyte aldose reductase.

    Kumamoto Y, Takamura Y, Kubo E, Tsuzuki S, Akagi Y.

    Exp Eye Res. 2007 Sep;85(3):393-9. Epub 2007 Jun 19.PMID: 17655844 [PubMed - indexed for MEDLINE]Related articles

    15.

    Renal and retinal microangiopathy after 15 years of follow-up study in a sample of Type 1 diabetes mellitus patients.

    Romero P, Salvat M, Fernández J, Baget M, Martinez I.

    J Diabetes Complications. 2007 Mar-Apr;21(2):93-100.PMID: 17331857 [PubMed - indexed for MEDLINE]Related articles

    17.

    The significance of the prepubertal diabetes duration for the development of retinopathy and nephropathy in patients with type 1 diabetes.

    Olsen BS, Sjølie AK, Hougaard P, Johannesen J, Marinelli K, Jacobsen BB, Mortensen HB; Danish Study Group of Diabetes in Childhood.

    J Diabetes Complications. 2004 May-Jun;18(3):160-4.PMID: 15145327 [PubMed - indexed for MEDLINE]Related articles

    19.

    Plasma 3-deoxyglucosone elevation in chronic renal failure is associated with increased aldose reductase in erythrocytes.

    Hasuike Y, Nakanishi T, Otaki Y, Nanami M, Tanimoto T, Taniguchi N, Takamitsu Y.

    Am J Kidney Dis. 2002 Sep;40(3):464-71.PMID: 12200796 [PubMed - indexed for MEDLINE]Related articles

    20.

    Relationship between serum soluble E-selectin levels and development of diabetic retinopathy in patients with type 2 diabetes.

    Ersanli D, Top C, Oncül O, Aydin A, Terekeci H.

    Scand J Clin Lab Invest. 2007;67(5):474-9.PMID: 17763183 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data